Exploring disparities and novel insights into metabolic and cardiovascular comorbidities among COVID-19 patients in Mexico.

ABSTRACT:

Introduction

The COVID-19 pandemic, especially its early stages, sparked extensive discussions regarding the potential impact of metabolic and cardiovascular comorbidities on the severity and fatality of SARS-CoV-2 infection, yielding inconclusive outcomes. In this study, we delve into the prevalence of metabolic and cardiovascular comorbidities within COVID-19 patients in Mexico.

Methods

Employing a retrospective observational study design, we collected data from official databases encompassing COVID-19 patients admitted to both public and private hospitals in Mexico City.

Results

Our investigation unveiled a noteworthy incongruity in the prevalence of metabolic and cardiovascular comorbidities among COVID-19 patients, with a particular emphasis on obesity, hypertens

SUBMITTER: Lopez-Cuevas JA 

PROVIDER: S-EPMC10623435 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature